Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Oligonucleotides are short DNA or RNA molecules, oligomers, that have a wide range of applications in genetic testing, research, and forensics. Commonly made in the laboratory by solid-phase chemical synthesis, these small bits of nucleic acids can be manufactured as single-stranded molecules with any user-specified sequence, and so are vital for artificial gene synthesis, polymerase chain reaction (PCR), DNA sequencing, library construction and as molecular probes.
Oligonucleotide therapeutics have attracted drug manufacturers to guarantee lower drug advancement costs, and the capacity to achieve targets that are not achieved by traditional small molecule drugs. Various clinical candidates have progressed, and a few drugs seem balanced for regulatory approvals. Large pharmaceutical organizations appear to once again investing and putting resources into oligonucleotides through authorizing licensing deals, partnerships, and acquisitions.
In 2018, the global Oligonucleotide Pool market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Oligonucleotide Pool status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oligonucleotide Pool development in United States, Europe and China.
The key players covered in this study
Agilent Technologies
Creative Biogene
CustomArray
Integrated DNA Technologies
MYcroarray
Sigma Aldrich
TriLink BioTechnologies
Twist Bioscience
Market segment by Type, the product can be split into
DNA Pool
RNA Pool
Market segment by Application, split into
Diagnostics
Therapeutics
Research
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Oligonucleotide Pool status, future forecast, growth opportunity, key market and key players.
To present the Oligonucleotide Pool development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oligonucleotide Pool are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Oligonucleotide therapeutics have attracted drug manufacturers to guarantee lower drug advancement costs, and the capacity to achieve targets that are not achieved by traditional small molecule drugs. Various clinical candidates have progressed, and a few drugs seem balanced for regulatory approvals. Large pharmaceutical organizations appear to once again investing and putting resources into oligonucleotides through authorizing licensing deals, partnerships, and acquisitions.
In 2018, the global Oligonucleotide Pool market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Oligonucleotide Pool status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oligonucleotide Pool development in United States, Europe and China.
The key players covered in this study
Agilent Technologies
Creative Biogene
CustomArray
Integrated DNA Technologies
MYcroarray
Sigma Aldrich
TriLink BioTechnologies
Twist Bioscience
Market segment by Type, the product can be split into
DNA Pool
RNA Pool
Market segment by Application, split into
Diagnostics
Therapeutics
Research
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Oligonucleotide Pool status, future forecast, growth opportunity, key market and key players.
To present the Oligonucleotide Pool development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Oligonucleotide Pool are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
